Page last updated: 2024-08-22

valnoctamide and Cytomegalovirus Infections

valnoctamide has been researched along with Cytomegalovirus Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bordey, A; Hsieh, LS; Ornaghi, S; Paidas, MJ; van den Pol, AN; Vergani, P1
Davis, JN; Gorres, KL; Miller, G; Ornaghi, S; Paidas, MJ; van den Pol, AN1

Other Studies

2 other study(ies) available for valnoctamide and Cytomegalovirus Infections

ArticleYear
Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017, 07-19, Volume: 37, Issue:29

    Topics: Amides; Animals; Animals, Newborn; Antiviral Agents; Cognition Disorders; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Encephalitis, Viral; Female; Male; Mice; Mice, Inbred C57BL; Treatment Outcome

2017
Mood stabilizers inhibit cytomegalovirus infection.
    Virology, 2016, Volume: 499

    Topics: Amides; Animals; Cell Line; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Disease Models, Animal; Female; Humans; Male; Mice; Muromegalovirus; Tranquilizing Agents; Valproic Acid; Viral Load; Virus Replication

2016